Please login to the form below

Not currently logged in
Email:
Password:

Otmar Wiestler appointed to Bayer supervisory board

He replaces Klaus Kleinfeld

edit-Otmar-D-WiestlerGermany-based Bayer has appointed Otmar Wiestler to its supervisory board with immediate effect.

Since January 2004 Wiestler has been chairman of Bayer's management board and scientific director of the German cancer research centre in Heidelberg, Germany. He has also been chairman of the advisory committee and a member of the board of German Cancer Aid.

In addition to these roles, he served in the executive committee of the Helmholtz Association from 2007 to 2012.

Wiestler succeeds Klaus Kleinfeld, who left the position in September in order to concentrate on other office and honorary posts, some of which are located in the US.

In regards to the appointment, Werner Wenning, chairman of Bayer's supervisory board, said: “We would like to thank Mr Kleinfeld for our very successful and trusting cooperation. In Prof Wiestler we have found a competent successor with extensive scientific expertise.”

9th October 2014

From: Research, Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics